Biparametric MRI-based radiomics for prediction of clinically significant prostate cancer of PI-RADS category 3 lesions. Lu F, Zhao Y, Wang Z, Feng N, et al. BMC Cancer 2025;25:615.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu F, Zhao Y, Wang Z, Feng N, et al. Biparametric MRI-based radiomics for prediction of clinically significant prostate cancer of PI-RADS category 3 lesions. BMC Cancer 2025;25:615.
PMID: 40188349